These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9723081)

  • 21. Therapeutic drug monitoring of gentamicin: evaluation of five nomograms for initial dosing at Al-Amiri Hospital in Kuwait.
    Al-Lanqawi Y; Capps P; Abdel-hamid M; Abulmalek K; Phillips D; Matar K; Sharma P; Thusu A
    Med Princ Pract; 2007; 16(5):348-54. PubMed ID: 17709922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Just a repeat' - When drug monitoring is indicated.
    Lucas C; Donovan P
    Aust Fam Physician; 2013; 42(1-2):18-22. PubMed ID: 23529454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antidigoxin Fab fragments and digoxin monitoring: a challenge for the biologist].
    Parant F; Ducluzeau R; Lardet G; Gagnieu MC; Moulsma M
    Ann Biol Clin (Paris); 2003; 61(6):645-53. PubMed ID: 14711605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discordant results from "real-world" patient samples assayed for digoxin.
    Jones TE; Morris RG
    Ann Pharmacother; 2008 Dec; 42(12):1797-803. PubMed ID: 19033482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Symptoms of severe digoxin intoxication in patients hospitalized in geriatric wards].
    Rajska-Neumann A; Chmielewski Z; Jóźwiak A; Wieczorowska-Tobis K
    Przegl Lek; 2004; 61(4):401-4. PubMed ID: 15521614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic drug monitoring: clinical practice].
    Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic analysis of selected antibiotics in calves.
    Luderer JR; Aber RC; Myers JL; Prophet GA; Pierce WS
    Trans Am Soc Artif Intern Organs; 1982; 28():159-63. PubMed ID: 7164233
    [No Abstract]   [Full Text] [Related]  

  • 28. What is a doctor to do...with digoxin?
    Pollak PT
    Can J Cardiol; 2005 Mar; 21(3):287-8. PubMed ID: 15776119
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of analytical inaccuracy on dose adjustment for gentamicin using the Abbottbase Pharmacokinetic Systems.
    Bouzas L; Hermida J; Tutor JC
    Clin Lab; 2004; 50(3-4):187-91. PubMed ID: 15074474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The early bactericidal activity of amikacin in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):533-8. PubMed ID: 11409580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding therapeutic drug monitoring.
    Shirrell D; Gibbar-Clements T; Dooley R; Free C
    Am J Nurs; 1999 Jan; 99(1 Pt 1):42-4. PubMed ID: 9932054
    [No Abstract]   [Full Text] [Related]  

  • 32. A DNA-Based Assay for Digoxin Detection.
    Kjelstrup MV; Nielsen LDF; Hansen-Bruhn M; Gothelf KV
    Biosensors (Basel); 2018 Mar; 8(1):. PubMed ID: 29509662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
    Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD
    J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers.
    Adamis G; Papaioannou MG; Giamarellos-Bourboulis EJ; Gargalianos P; Kosmidis J; Giamarellou H
    Int J Antimicrob Agents; 2004 Feb; 23(2):144-9. PubMed ID: 15013039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-measurement therapeutic drug monitoring of the HIV/AIDS drugs abacavir, zidovudine, lamivudine, efavirenz, nevirapine, lopinavir and nelfinavir.
    Donnerer J; Haas BJ; Kessler HH
    Pharmacology; 2008; 82(4):287-92. PubMed ID: 18931536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P; Szechciński J
    Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protocol for clinical monitoring of juvenile idiopathic arthritis].
    Canhão H; Fonseca JE; Santos MJ; Gomes JA
    Acta Reumatol Port; 2007; 32(3):277-81. PubMed ID: 17928788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of amikacin nephrotoxicity in the hematology/oncology population.
    Kiel PJ; Lo M; Stockwell D; Patel GP
    Am J Ther; 2008; 15(2):131-6. PubMed ID: 18356633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.